FOXP3 and rheumatoid arthritis: Mammalian target of rapamycin (mTOR) signaling has recently emerged as a key effector molecule in Syk activation (25) which seems to be particularly important for inhibiting FOXP3 transcription (26) and has been implicated in RA (27).